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A B S T R A C T
Background: Critically ill patients suﬀering from fecal incontinence have a major risk of developing incon-
tinence-associated dermatitis (IAD). The presence of moisture and digestive enzymes (lipase, protease) nega-
tively inﬂuences skin barrier function. Additional risk factors will make some patients even more vulnerable than
others. In order to provide (cost) eﬀective prevention, this speciﬁc patient population should be identiﬁed
timely.
Objectives: To identify independent risk factors for the development of IAD category 2 (skin loss) in critically ill
patients with fecal incontinence.
Design: A cross-sectional observational study.
Setting and participants: The study was performed in 48 ICU wards from 27 Belgian hospitals. Patients of 18 years
or older, with fecal incontinence at the moment of data collection, were eligible to participate. Patients with
persistent skin redness due to incontinence (IAD category 1) were excluded.
Methods: Potential risk factors were carefully determined based on literature and expert consultations. Data
were collected over a period of eight months by trained researchers using patient records and observation of skin
care practices. At the time a patient was included in the study, all relevant data from the past six days, or since
admission at the ICU, were recorded. Simultaneously, direct skin observations were performed and high deﬁ-
nition photographs were ratiﬁed by an expert IAD researcher. A multiple binary logistic regression model was
composed to identify independent risk factors. Variables with P < .25 in single binary logistic regression
analyses were added to the multiple model using a forward procedure. A cut-oﬀ value of P < .1 was established
to retain variables in the ﬁnal model. Nagelkerke’s R2 and Hosmer-Lemeshow statistic were calculated as
measures of model ﬁt.
Results: The sample comprised of 206 patients, of which 95 presented with IAD category 2, and 111 were free of
IAD. Seven independent risk factors were identiﬁed: liquid stool [odds ratio (OR) 4.69; 95% conﬁdence interval
(CI) 2.28–9.62], diabetes (OR 2.89; 95% CI 1.34–6.27), age (OR 1.05; 95% CI 1.02–1.08), smoking (OR 2.67;
95% CI 1.21–5.91), non-use of diapers (OR 2.97; 95% CI 1.39–6.33), fever (OR 2.60; 95% CI 1.23–5.53), and low
oxygen saturation (OR 2.15; 95% CI 1.03–4.48). Nagelkerke’s R2 was 0.377. The Hosmer-Lemeshow statistic
indicated no signiﬁcant diﬀerence between the observed and expected values (p= .301).
Conclusions: Liquid stool, diabetes, age, smoking, non-use of diapers, fever, and low oxygen saturation were
independently associated with IAD category 2 in critically ill patients with fecal incontinence.
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What is already known about the topic?
• Critically ill patients with fecal incontinence are at high risk for
incontinence-associated dermatitis (IAD) due to the presence of in-
testinal enzymes, and bacterial ﬂora.
• Timely application of a structured skin care regimen, consisting of
incontinence management, gently cleansing, and application of a
leave-on product, are recommended to prevent IAD development.
• Additional risk factors contribute to a higher vulnerability and, the
need for more speciﬁc interventions.
What this paper adds
• Independent risk factors were identiﬁed in a sample of 206 critically
ill patients with fecal incontinence from 48 ICU units in 27 Belgian
hospitals, by composing a multiple binary logistic regression model.
• Liquid stool, diabetes, age, smoking, not using adult diapers, fever,
and frequent low oxygen saturation were factors increasing the risk
of IAD category 2 (skin loss).
• The risk factors identiﬁed may contribute to timely identiﬁcation of
high risk patients, and the development of speciﬁc preventive in-
terventions.
1. Introduction
In critically ill patients, maintaining skin integrity is a major chal-
lenge for nurses. The skin is the largest human organ. The upper skin
layer, the stratum corneum, consists of 25–30 layers of ﬂattened kera-
tinocytes which are continuously shed and replaced. The keratinocytes
protect the skin against micro-organisms, abrasion, heat, and chemi-
cals. In addition, the lipid layers, in which the keratinocytes are em-
bedded, protect against skin dehydration through retarding the entry of
water and inhibiting the evaporation of water (Beeckman et al., 2015;
Tortora and Derrickson, 2014). In patients admitted to the intensive
care unit (ICU), various illness and treatment related factors compro-
mise this skin barrier function, such as hemodynamic instability, poor
tissue perfusion and tissue oxygenation, presence of medical devices,
restricted mobility, medication (e.g. sedatives, vasoactive drugs, corti-
costeroids), incontinence, and malnutrition (Alderden et al., 2017;
Beeckman et al., 2015; Gonzalez-Mendez et al., 2017; National Pressure
Ulcer Advisory Panel et al., 2014). Furthermore, due to diminished
cognitive and sensory functioning, most of these patients are not able to
adequately react upon pain due to pressure, or irritation caused by
moisture. As a consequence, care providers are responsible to provide
timely and adequate skin care, to prevent the burden of skin damage in
this highly vulnerable patient population.
A common skin problem in critically ill patients is incontinence-
associated dermatitis (IAD), with prevalence ﬁgures varying between
15.0% and 36.0% (Bliss et al., 2011; Chianca et al., 2017; Coyer et al.,
2017; Driver, 2007). IAD is deﬁned as an inﬂammatory response of the
upper dermis caused by frequent or prolonged contact with urine and/
or feces (Gray et al., 2012). The main symptoms of IAD are erythema
and oedema of the stratum corneum, sometimes accompanied by bullae
with serous exudates, erosion, or secondary cutaneous infection
(Beeckman et al., 2016). To promote a standardised description and
documentation of IAD in research and practice, a new classiﬁcation tool
has recently been developed and internationally validated: the Ghent
Global IAD Categorisation Tool (GLOBIAD) (Beeckman et al., 2017).
The GLOBIAD distinguishes two categories of IAD based on the severity
of the skin problem. Category 1 corresponds to the presence of persis-
tent redness without skin loss. Category 2 corresponds to the presence
of skin loss, which can be skin erosion, denudation or excoriation
(Beeckman et al., 2017) (Fig. 1).
In critically ill patients, fecal incontinence is the major cause of IAD,
as most patients have an indwelling urinary catheter, are sedated and
receive enteral nutrition (Jack et al., 2010). Several studies determined
that patients with fecal incontinence were at higher risk of developing
IAD than patients with urinary incontinence (Bliss et al., 2006a,b;
Kottner et al., 2014). Feces consist for 75% of water and 25% of solid
matter such as inorganic salts, epithelial cells from gut mucosa, bac-
teria, products of bacterial decomposition, unabsorbed digested mate-
rial (including digestive enzymes), and indigestible parts of food
(Tortora and Derrickson, 2014). This unique composition compromises
the skin barrier function through diﬀerent mechanisms (Beeckman
et al., 2009; Gray et al., 2012). Moisture contributes to overhydration of
the stratum corneum which causes swelling of the corneocytes and
disruption of the intercellular lipid bilayers (Ichikawa-Shigeta et al.,
2014). As a result, the permeability of the skin to digestive enzymes
(proteases, lipases), other irritants, and micro-organisms increases,
which exacerbates inﬂammation (Gray et al., 2012). Digestive enzymes
break down the cell-connecting proteins (desmosomes) and lipids of the
stratum corneum, further diminishing skin barrier function (Beeckman
et al., 2015; Kottner and Beeckman, 2015). In the presence of urine,
urease, produced by fecal bacteria, transforms urea into ammonia. This
triggers a rise in skin pH which aﬀects stratum corneum cohesion and
skin microbiome (Beeckman et al., 2015).
IAD prevention focuses on minimising contact of the skin with urine
and/or feces and maintaining or enhancing skin barrier properties
(Beeckman, 2017). To minimise contact between skin and urine and/or
feces, the use of absorbent products (e.g. diapers and underpads) is
current practice. Smooth and breathable materials are recommended,
which are regularly changed (Kottner and Beeckman, 2015). In addi-
tion, the skin should be gently cleansed with a pH-balanced skin
cleanser, or impregnated wipe, following each episode of incontinence.
The use of soap and water is not recommended (Beeckman et al., 2016).
The application of leave-on products with moisturising and skin pro-
tecting properties has been described as an essential component of
preventive strategies (Beeckman et al., 2015). A recent Cochrane re-
view reported that a comprehensive range of products and procedures
for IAD prevention already exist (Beeckman et al., 2016). Nonetheless,
as described above, IAD prevalence remains high.
Besides the costs associated with the use of skin cleansers, leave-on
products, changing bed sheets, laundry, aprons, gloves, and waste
processing (Avsar and Karadag, 2017; Beeckman et al., 2015), IAD
management is a time consuming practice for nurses. High quality re-
search reporting on the total cost of IAD management (product costs
and cost associated with nursing time) is scarce (Lichterfeld-Kottner
et al., 2017). Total costs (nursing time, cost of products, and supplies)
from the provider’s perspective were estimated between 0.89 USD and
1.74 USD per incontinence episode (n= 981) (Bliss et al., 2007), and
between 12.26 USD and 46.20 USD per week (n= 6) (Woo, 2014),
associated with the brand of skin care products used. In a more recent
study, total costs (nursing time, product cost) from the provider’s per-
spective were estimated between 135.68 USD and 108.77 USD per
patient (n=154) (Avsar and Karadag, 2017). Nursing time is con-
sidered to be the major cost driver (Beeckman et al., 2015).
In order to provide (cost) eﬀective and timely IAD prevention, pa-
tients at risk of developing IAD should be identiﬁed as early as possible.
Risk factors for the development of IAD were yet identiﬁed in various
settings. In four studies in nursing homes (n= 381 till n= 10 713), a
range of independent risk factors were identiﬁed using multivariate
analyses: IAD category 1, restricted mobility, functional deﬁcits in ac-
tivities of daily living, friction and shear, perfusion problems, oxyge-
nation problems, nutritional support, restraint use, perineal pressure
injury, cognitive deﬁcits, not receiving preventive interventions,
number of comorbidities, fever, fecal incontinence, double incon-
tinence, higher BMI, fall risk, and female gender (Bliss et al., 2017,
2006b; Boronat-Garrido et al., 2016; Van Damme et al., 2017). Most of
these studies used secondary data-analyses (Bliss et al., 2017, 2006b;
Boronat-Garrido et al., 2016). Kottner et al. (2014) also performed
secondary data analyses on a sample of 3713 incontinent nursing home
residents, hospitalised patients, as well as adults receiving home care.
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Body Mass Index (BMI), fecal incontinence, diabetes mellitus, moisture,
and friction and shear problems were identiﬁed as independent risk
factors for IAD development. In two prevalence studies, performed in
the acute care setting (n= 376–608), poor nutritional status, and semi-
formed and liquid stool has been associated with IAD using single
analyses (Campbell et al., 2014; Junkin and Selekof, 2007). One last
study was performed in critically ill patients. In this study (n=45),
using a prospective design, Bliss et al. (2011) determined that the time
to IAD development was signiﬁcantly shorter in fecal incontinent pa-
tients with loose or liquid stool or with diminished cognitive awareness.
The literature overview conﬁrms that fecal incontinence is a clear
risk factor for IAD. In addition, a lack of evidence exist on additional
risk factors in high risk patient populations not living in nursing homes.
However, this evidence is necessary to develop and implement early
preventive interventions.
The aim of this study was to identify independent risk factors for the
development of IAD category 2 in critically ill patients with fecal in-




A cross-sectional observational study was designed. Direct skin ob-
servations were performed at one point in time and, simultaneously,
potential IAD risk factors were measured. Patients with IAD category 2
were compared with patients without IAD to identify signiﬁcant dif-
ferences in the prevalence of potential IAD risk factors.
2.2. Settings and participants
The study was conducted at the intensive care unit (ICU), including
cardiac/coronary care units (CCU), of a convenience sample of Belgian
hospitals. All hospitals in the Flemish speaking region of Belgium, with
at least eight intensive care beds, were invited to participate (n=41).
In total 27 hospitals, including 48 wards, and 624 beds, comprised the
study sample.
Patients of 18 years and older, with fecal incontinence, were eligible
to participate. Fecal incontinence was deﬁned as any involuntary loss of
feces since admission to the ICU or CCU and at least during the last six
days. This reference period of six days was based on the study of Bliss
et al. (2011) which determined that the median time to IAD develop-
ment in critically ill patients was 4 days (range 1 till 6 days). Patients
Fig. 1. Ghent Global IAD Categorisation Tool (GLOBIAD).
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were excluded if IAD category 1 (persistent redness), according to the
(GLOBIAD) (Beeckman et al., 2017), was present. IAD category 1 is a
known risk factor for the development of IAD category 2 (Van Damme
et al., 2017).
2.3. Variables
A list of 19 potential IAD risk factors, including variables measuring
these risk factors, was developed based on a literature review (risk
factor studies, consensus documents, reviews), and clinical expertise of
the research group. This list was further optimised based on expert
consultations during the preparation of the study, leading to the addi-
tion of four potential risk factors. Table 1 describes the 23 potential risk
factors studied. Cut-oﬀ values were established based on lab reference
values, guidelines from the World Health Organisation (World Health
Organization, 2011), scientiﬁc reports (Clyne and Olshaker, 1999; Patel
and Kress, 2012; Traub and Wijdicks, 2016; van der Geest et al., 2016),
and expert advice. The dependent variable was IAD category 2, deﬁned
as skin inﬂammation, due to contact with stool, manifested as skin
erosion, denudation, or excoriation (Fig. 1) (Beeckman et al., 2017).
2.4. Data collection
Data were collected by ﬁve trained researchers between 4 October
2016 and 31 May 2017. All researchers were registered nurses with
experience as a general ward nurse (n=5), and ICU nurse (n=2).
Four of them studied an academic MSc programme in Nursing and
Midwifery and one was a PhD student experienced in IAD research. The
researchers were trained by the ﬁrst author in the identiﬁcation and
categorisation of IAD, as well as the diﬀerentiation between IAD and
pressure ulcers. For this purpose, a validated e-learning tool was used:
the Pressure Ulcer Classiﬁcation Set (PuClas3) by the European
Pressure Ulcer Advisory Panel (EPUAP) (Beeckman and Schoonhoven,
2015). In addition, a specialised wound photographer was involved to
develop a protocol for wound photography.
At the time of inclusion, high deﬁnition photographs were taken
from the peri-anal area, buttocks, and anal cleft using a Nikon D3300
reﬂex camera with standardised settings: use of ﬂashlight, semi-auto-
matic mode with aperture priority (F8), ISO 200, ‘ﬂash’ preset white
balance, focus 20mm (overview) or 50mm (detail). All pictures were
reviewed by the ﬁrst author and ratiﬁed by an expert IAD researcher to
conﬁrm the diagnosis of IAD category 2 and exclude any patient with
IAD category 1 in the ﬁnal analyses.
Since the time to IAD development was estimated between 1 up to
6 days, all relevant data from the past six days prior to inclusion were
recorded (Bliss et al., 2011). For this purpose, a standardised data
collection form was designed and pilot tested by two researchers in 11
patients in three diﬀerent hospitals. During the pilot test, we decided on
Table 1
Potential IAD risk factors.
Risk factors Descriptiona
1. Age Age in years from date of birth
2. Gender Gender
3. Length of stay Amount of days at intensive care unit
4. Smoking History of smoking mentioned in patient record or by patient
5. APACHE II APACHE II score within 24 h after admission
6. Mechanical ventilation Presence and duration of mechanical ventilation
7. Dialysis Presence of dialysis
8. Infection C-reactive protein levelb:> 10mg/L;> 40mg/L;> 200mg/L
Leucocyte countb:> 10×109/L;> 15×109/L;> 20×109/L
9. Fever Highest daily temperature> 38 °C (presence and duration)
10. Tissue oxygenation Systolic arterial blood pressurec> 160mmHg or< 100mmHg
Diastolic blood pressurec> 100mmHg or< 60mmHg
Mean arterial blood pressurec> 110mmHg or< 65mmHg
PaO2c<80mmHg
SaO2c< 95%
(Duration of) administration of vasopressors
(Duration of) administration of inotropics
11. Antibiotics (Duration of) administration, and amount of antibiotics
Administration of penicillin
12. Skin condition (Duration of) administration of steroids
Presence of obesity or underweightd
13. Malnutrition Serum albumin levelb< 35 g/L;< 30 g/L;< 25 g/L;< 20 g/L
14. Diabetes Presence of diabetes type I or II
15. Use of continence products Use of diapers
16. Skin care Skin cleansing product at incontinence (soap and water, cleansing foam or milk, antiseptics, impregnated disposable washgloves)
Application of skin barrier products (barrier cream or spray)
17. Urinary incontinence Presence of urinary incontinence
18. Loose or liquid stool Presence and duration of stool type 6 or 7 according to Bristol Stool Chart
19. Clostridium diﬃcile Clostridium diﬃcile identiﬁed in feces sample
20. Mechanical chaﬁng Problem or potential problem of friction and shear according to Braden subscale
Bedbound
21. Low hemoglobin level Hemoglobin levelb< 8.0 g/dL,< 9.0 g/dL,< 10 g/dL
22. Nutritional support (Duration of) administration of enteral nutrition (during the whole stay at ICU/CCU)
(Duration of) administration of parenteral nutrition (during the whole stay at ICU/CCU)
23. Diminished cognitive awareness Glasgow Coma Scale< 9
Richmond Agitation-Sedation Scale<−3,<−4
IAD: incontinence-associated dermatitis, APACHE II: Acute Physiology and Chronic Health Evaluation, PaO2: partial oxygen pressure, SpO2: oxygen saturation measured by pulse
oximetry, ICU: intensive care unit, CCU: cardiac/coronary care unit.
a Unless indicated, only data from the last six days before data collection were used.
b For laboratory results, the ﬁrst result was registered for each day (during the last six days).
c For clinical parameters, the percentage of measurements above or below the cut-oﬀ was registered for each day (during the last six days).
d Obesity and underweight were deﬁned based on visual assessment by both a nurse and a researcher, as recent weight was not measured or reliably reported for the majority of ICU
patients.
N. Van Damme et al. International Journal of Nursing Studies 81 (2018) 30–39
33
the mode of registering clinical parameters which were measured sev-
eral times a day (e.g. blood pressure, partial oxygen pressure). Medical
doctors were consulted to inform our decisions. In addition, we noticed
that erythrocyte sedimentation rate (inﬂammation) as well as pre-
albumin (malnutrition) were not determined anymore in practice.
Based on the ﬁndings of the pilot study, we developed a user guide for
all researchers to enhance reliability of the data collection.
2.5. Measurement instruments
Validated measurement instruments were used to describe the se-
verity of disease [Acute Physiology and Chronic Health Evaluation
(Apache II) (Knaus et al., 1985)], feces consistency [Bristol Stool Chart
(Lewis and Heaton, 1997)], and cognitive awareness [Glasgow Coma
Scale (Prasad, 1996)]. The variable ‘Presence of mechanical chaﬁng’
was part of the Braden scale for pressure ulcer risk assessment
(Bergstrom et al., 1987).
The outcome variable, IAD category 2, was assessed using the
GLOBIAD (Fig. 1) (Beeckman et al., 2017). This instrument categorises
IAD, based on visual skin assessment, into two main categories. For
each category, a picture was provided and critical as well as additional
criteria were described. The critical criterion for IAD category 1 was
persistent redness, whether or not composed of diﬀerent tones; the
critical criterion for IAD category 2 was skin loss, which can be ex-
pressed as skin erosion, denudation, or excoriation. Each category was
subdivided into two subcategories: no clinical signs of infection (A), and
clinical signs of infection (B). The GLOBIAD was developed in colla-
boration with 34 international experts and psychometric validation was
performed in a sample of 823 clinicians from 30 countries. Interrater
reliability (Fleiss kappa) and intrarater reliability (Cohen’s kappa) for
distinguishing between IAD category 1 and IAD category 2 were sub-
stantial [Fleiss Kappa: 0.65 (95% CI 0.65–0.65), Cohen’s kappa: 0.76
(95% CI 0.75–0.77)]. The diagnostic accuracy was high [mean sensi-
tivity: 90% (95% CI 0.89–0.91), mean speciﬁcity: 84% (95% CI
0.83–0.85)].
2.6. Statistical methods
2.6.1. Sample size calculation
Sample size was determined to include at least 10 cases (partici-
pants with IAD category 2) per potential risk factor eligible to be en-
tered into the multiple binary logistic regression model (Hosmer et al.,
2013; Wilson VanVoorhis and Morgan, 2007). Based on possible colli-
nearity between risk factors, and existing research (Boronat-Garrido
et al., 2016; Kottner et al., 2014), we estimated that a maximum of nine
potential risk factors could be included in the multiple model. As a
consequence, a sample consisting of at least 90 participants with IAD
category 2 and an equal amount without IAD was deﬁned.
2.6.2. Data analysis
Data were analysed using IBM® SPSS® Statistics (Version 24, IBM
Corporation, New York, NY). Data not available for particular patients
(e.g. serum albumin level) were coded as missing data. Categorical
variables were described using frequencies (percentages). Continuous
variables were checked for normal distribution using Shapiro-Wilk test,
Q–Q plots, and box-and-whisker plots. Normally distributed continuous
variables (e.g. age) were described using means and standard devia-
tions (SD). Non-normally distributed continuous variables (e.g. dura-
tion of fever) were recoded into categories based on relative frequencies
and meaningfulness for clinical decision making in critically ill patients.
Lab values were recoded in two categories: at least one measurement
above or below the cut-oﬀ (0= no; 1= yes). Clinical parameters and
lab values measured several times a day [e.g. mean arterial pressure,
partial oxygen pressure (PaO2)], were also recoded into two categories:
at least one day most of the time (≥50%) above or below the cut-oﬀ
(0= no; 1= yes).
To identify risk factors independently associated with the develop-
ment of IAD category 2, a multiple binary logistic regression model was
composed through a purposeful selection process of variables (Bursac
et al., 2008). In a ﬁrst step, all variables were analysed for signiﬁcant
association with the development of IAD category 2 in single binary
logistic regression analyses. In a second step, variables with p < .25 in
the single analyses were entered one by one into a multiple binary lo-
gistic regression model and retrieved if p < .1. This process was per-
formed iteratively until the addition of none of the remaining variables
resulted in p < .1. The initial list of candidate variables with p < .25
was reduced to include the variables being most meaningful for clinical
decision making in critically ill patients in the iterative selection pro-
cess. For example, C-reactive protein (CRP) > 40mg/L was preferred
above CRP > 10mg/L. Mean arterial pressure was considered more
meaningful than systolic and diastolic arterial blood pressure, as a
measure of tissue perfusion. If ‘presence’ as well as ‘duration’ of a
variable (e.g. presence of fever and duration of fever) were described,
‘presence’ was considered as being more meaningful.
In a third step, all remaining variables, with p > .25 in the single
analyses, were entered one by one to the multiple model. This step
allowed identifying variables appearing to be meaningful in the pre-
sence of other variables (Bursac et al., 2008).
Multicollinearity between variables was explored by calculating
Pearson’s rank correlation coeﬃcient [two continuous variables, cut-oﬀ
r≥ 0.6 (Chan, 2004a)], independent sample t-test (one continuous and
one nominal variable), or chi square test (two nominal variables). Na-
gelkerke’s R2 and Hosmer-Lemeshow statistic were calculated as mea-
sures of model ﬁt (Chan, 2004b). The signiﬁcance level was set at
α < 0.05.
2.7. Ethical approval and trial registration
This study was performed according to the ethical guidelines of the
Declaration of Helsinki and approved by the Ethics Review Committee
of all participating hospitals (B670201629184). All participants or their
representatives provided oral and written informed consent. The study
was registered at ClinicalTrial.gov (NCT02996357).
3. Results
3.1. Characteristics of the participants
The study sample consisted of 206 participants of which 138
(67.0%) were male. Mean age of the participants was 65.1 years
[standard deviation (SD) 14.9] and mean APACHE II score was 23.20
(SD 7.5). The median length of stay was 14 days (interquartile range
8–26, range 1–82). Of all participants, 199 (96.6%) had indwelling
urinary catheters at the time of data collection and were deﬁned as not
urinary incontinent. The most common primary diagnoses at admission
were cardiopulmonary conditions (83/206, 40.3%), sepsis (29/206,
14.1%), and cerebral trauma or stroke (31/206, 15%). Of all partici-
pants, 95 had IAD category 2 at the time of data collection and 4 (4.2%)
of these presented clinical signs of secondary skin infection [category
2 B according to the GLOBIAD (Beeckman et al., 2017)]. Table 2 pro-
vides an overview of the sample characteristics.
3.2. Risk factors associated with the development of IAD category 2
Single binary logistic regression revealed 18 variables signiﬁcantly
associated with the development of IAD category 2 (p < .05) (see
Table 3). Of all variables, 34 had a p < .25.
After removing less clinically relevant, or correlating variables, 20
variables were included in the iterative process to compose the multiple
binary regression model. Nine of these variables remained in the model
(see Table 4). In a ﬁnal step, the variables with p > .25 in the single
analyses, were added one by one to the preliminary model to determine
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if some of these variables were meaningful in the presence of the other
variables. This step resulted in the addition of one supplementary
variable, administration of vasopressors, to the ﬁnal model. The pre-
sence of liquid stool [OR 4.69; 95% conﬁdence interval (CI) 2.28–9.62],
diabetes (OR 2.89; 95% CI 1.34–6.27), age (OR 1.05; 95% CI
1.02–1.08), smoking (OR 2.67; 95% CI 1.21–5.91), no use of diapers
(OR 2.97; 95% CI 1.39–6.33), fever (OR 2.60; 95% CI 1.23–5.53), and
low oxygen saturation (OR 2.15; 95% CI 1.03–4.48) were in-
dependently associated with the development of IAD category 2 in fecal
incontinent critically ill patients. Our multiple binary logistic regression
model explained 37.7% of variance in the development of IAD (Na-
gelkerke’s R2 0.377). The Hosmer-Lemeshow goodness of ﬁt test in-
dicated no signiﬁcant diﬀerence between the observed and the ex-
pected values (X2 9.511, degrees of freedom 8, p= .301).
4. Discussion
This study aimed to identify independent risk factors for the de-
velopment of IAD category 2 in critically ill adults with fecal incon-
tinence. Liquid stool, diabetes, age, smoking, non-use of diapers, fever,
and low oxygen saturation appeared to be independently associated
with the outcome of our study. Our ﬁndings deliver necessary knowl-
edge to support a more accurate IAD risk assessment which promotes
early identiﬁcation of high risk patients.
The risk factors identiﬁed were theoretically sound and in ac-
cordance with ﬁndings from other studies. Liquid stool was the stron-
gest predictor of developing IAD category 2. In patients with liquid
stool, the odds of developing IAD category 2 was almost ﬁve times as
high as in patients with loose or formed stool. It is known that if chyme
passes too quickly through the small intestine and feces passes too
quickly through the large intestine, the absorption of water and solid
matter decreases. As a consequence, liquid feces contain a larger
amount of water and unabsorbed solid matter (e.g. digestive enzymes)
(Tortora and Derrickson, 2014). The higher amount of digestive en-
zymes (proteases and lipases) is detrimental to the lipid matrix in which
the corneocytes are embedded, and the intercellular proteins (desmo-
somes) which link the corneocytes together (Beeckman et al., 2015). In
addition, overhydration of the stratum corneum increases the perme-
ability of the skin for irritants such as these digestive enzymes. Based on
these physiological insights, it is clear that skin inﬂammation is more
likely to occur in the presence of liquid stool than in the presence of
loose or formed stool (Beeckman et al., 2015; Gray et al., 2012). Si-
milarly, in the study of Bliss et al. (2011), the presence of loose or liquid
stool, without making a distinction, was determined as an independent
risk factor for IAD development in critically ill patients.
In patients with diabetes, as well as elderly patients, skin barrier
function is compromised due to physiological and morphological
changes. First, in these patients, skin is characterised by a decrease in
the proliferation, diﬀerentiation, and migration of keratinocytes, which
contributes to a thinner epidermis and a delayed wound healing. A
thinner epidermis is easier to penetrate for irritants due to the smaller
distance to be covered, increasing the risk of irritant contact dermatitis
(Dabrowska et al., 2017). Secondly, skin hydration in elderly and pa-
tients with diabetes is reduced because of a decrease in the production
of natural moisturising factor. Optimal skin hydration, however, is es-
sential for skin homeostasis (Dabrowska et al., 2017). In addition, the
reduction in acidic natural moisturising factor contributes to a rise in
skin pH (>6) which negatively inﬂuences the skin microbiome and
stratum corneum cohesion (Beeckman et al., 2015; Dabrowska et al.,
2017). Thirdly, in elderly and patients with diabetes, a decrease in
collagen production in the dermis has been determined in association
with a loss of skin elasticity (Beeckman et al., 2015). This reduction in
skin ﬂexibility has been associated with a decrease in cutaneous re-
sistance against tissue deformations (Luboz et al., 2015). Kottner et al.
(2014) also identiﬁed diabetes as an independent risk factor for IAD
development. If we compare our results concerning age with other
studies (Bliss et al. 2006b, 2011, 2015; Boronat-Garrido et al., 2016;
Kottner et al., 2014), we were the ﬁrst identifying this variable as an
IAD risk factor. However, it should be remarked that in four of these
latter studies, the participants were overall older (Bliss et al., 2006b;
Boronat-Garrido et al., 2016; Kottner et al., 2014) or younger (Bliss
et al., 2011). Nevertheless, from a physiological point of view, it is
reasonable to accept that age as well as diabetes are associated with a
higher vulnerability for the development of IAD category 2.
In our study, diapers were used in 54.9% of the patients to minimise
contact of the skin with urine and/or stool. In the other patients, only
underpads were used. The use of diapers has been associated with
changes in skin pH, occlusion, and prolonged contact with urine/stool,
increasing the risk of IAD (Gray et al., 2012). Over the last decade,
however, diapers were designed to optimise absorption capacity (e.g.
use of superabsorbent polymers), and permeability for air (Beguin et al.,
2010; Sugama et al., 2012). We determined that using diapers was more
protective against IAD category 2 than using underpads. Possible ex-
planations for our ﬁnding may be a lower absorbance capacity of un-
derpads, non-permeability for air at the down side, or a higher risk of
friction. However, further research on this issue is needed.
The three other independent risk factors identiﬁed, fever, low
oxygen saturation, and smoking, were factors negatively inﬂuencing
tissue oxygen supply (Bliss et al., 2006b; Brown, 1995). Oxygen is a
necessary component for the aerobe production of adenosine tripho-
sphate (ATP), used in several energy-demanding cellular processes
(Avishai et al., 2017; Tortora and Derrickson, 2014). In patients with
fever, cell metabolism and associated energy demand is increased and,
as a result, oxygen demand may exceed oxygen supply (Demarre et al.,
2015). In smokers, nicotine strongly enhances vasoconstriction of the
dermal blood vessels leading to hypoperfusion of the skin (Avishai
et al., 2017; Edvinsson et al., 2008). Insuﬃcient supply of oxygen and
nutrients diminishes tissue tolerance and increases the risk of devel-
oping IAD category 2 (Brown, 1995). Furthermore, it has been de-
scribed that smoking is associated with a decreased collagen synthesis
and a disturbance of the diﬀerent phases of the wound healing process
(Dabrowska et al., 2017). Diminished tissue oxygenation, measured in
diﬀerent ways, has also been identiﬁed as an independent risk factor for
IAD development in nursing home residents (Bliss et al., 2017, 2006b),
but not in critically ill patients (Bliss et al., 2011). It could be that the
sample size (n=45) of the latter study was too small (n= 45).
Although we identiﬁed seven independent risk factors, some IAD
risk factors identiﬁed in other studies, were not conﬁrmed. Friction and
shear, for example, was associated with IAD development in four stu-
dies including participants from nursing homes, home care and hospi-
tals (Bliss et al., 2006b; Kottner et al., 2014; Long et al., 2012; Van
Table 2
Characteristics of the participants (n=206).
Characteristics N n (%)/Mean (SD)/ Median
(IQR)
Male 206 138 (67.0)
Age (years) 205 65.1 (14.9)
Apache II score [Mean (SD)] 186 23.20 (7.5)
Length of stay [Median (IQR)] 206 14 (8–26)
Primary diagnosis 206
Cardiopulmonary condition 83 (40.3)
Sepsis 29 (14.1)
Cerebral trauma or stroke 31 (15.0)
Multiple trauma without cerebral
trauma
8 (3.9)




IAD category 2 206 95 (46.1)
SD: standard deviation, IQR: interquartile range (ﬁrst and third quartile), APACHE II:
acute physiology and chronic health evaluation II, IAD: incontinence-associated derma-
titis
N. Van Damme et al. International Journal of Nursing Studies 81 (2018) 30–39
35
Table 3
Univariate binary logistic regression for association between possible risk factors and IAD category 2 (n= 206).
IAD no IAD yes Total
Total n (%)/Mean (SD) Total n (%) Mean
(SD)
Total n (%) Mean
(SD)
P value OR
Age [mean (SD)] 111 62.02 (16.9) 94 68.65 (11.3) 205 65.06 (14.9) 0.002 1.033 (1.012–1.054)
Gender: male 111 78 (70.3) 95 60 (63.2) 206 138 (67) 0.280 0.725 (0.405–1.299)
Length of stay 111 95 206 0.302
1–10 days 35 (31.5) 38 (40.0) 73 (35.4)
11–20 days 38 (34.2) 24 (25.3) 62 (30.1) 0.122 0.582 (0.293–1.156)
> 20 days 38 (34.2) 33 (34.7) 71 (34.5) 0.504 0.800 (0.416–1.539)
Smoking 111 23 (20.7) 95 29 (30.5) 206 52 (25.2) 0.108 1.681 (0.892–3.168)
Apache II score [mean (SD)] 104 21.84 (7.1) 82 24.9 (7.7) 186 23.20 (7.5) 0.006 1.059 (1.017–1.104)
Mechanical ventilation
Presence of mechanical ventilation 111 72 (64.9) 95 64 (67.4) 206 136 (66.0) 0.705 0.894 (0.501–1.596)
Duration 110 92 202 0.619
0 days 39 (35.5) 31 (33.7) 70 (34.7)
1–3 days 15 (13.6) 9 (9.8) 24 (11.9) 0.562 0.755 (0.291–1.955)
4–6 days 56 (50.9) 52 (56.5) 108 (53.5) 0.614 1.168 (0.639–2.137)
Presence of dialysis 111 7 (6.3) 95 15 (15.8) 206 22 (10.7) 0.033 2.786 (1.085–7.155)
Presence of infection
C-reactive protein > 10mg/La 99 92 (92.7) 93 91 (97.8) 192 183 (95.3) 0.128 3.462 (0.700–17.112)
C-reactive protein > 40mg/La 99 74 (74.7) 93 76 (81.7) 192 150 (78.1) 0.244 1.510 (0.754–3.024)
C-reactive protein > 200mg/La 99 25 (25.3) 93 28 (30.1) 192 53 (27.6) 0.452 1.275 (0.676–2.404)
Leucocyte count > 10×109/La 99 79 (79.8) 93 75 (80.6) 192 154 (80.2) 0.883 1.055 (0.518–2.147)
Leucocyte count > 15×109/La 99 41 (41.4) 93 46 (49.5) 192 87 (45.3) 0.263 1.385 (0.783–2.449)
Leucocyte count > 20×109/La 99 15 (15.2) 93 25 (26.9) 192 40 (20.8) 0.048 2.059 (1.007–4.211)
Presence of fever (> 38 °C) 111 47 (42.3) 94 50 (53.2) 205 97 (47.3) 0.122 0.646 (0.372–1.124)
Duration of fever 111 94 205 0.067
0 days 64 (57.7) 44 (46.8) 108 (52.7)
1–3 days 29 (26.1) 39 (41.5) 68 (33.2) 0.033 1.956 (1.057–3.618)
4–6 days 18 (16.2) 11 (11.7) 29 (14.1) 0.784 0.889 (0.383–2.064)
Tissue oxygenation
Systolic arterial blood pressure > 160mmHgb 110 24 (21.8) 95 23 (24.2) 205 47 (22.9) 0.685 1.145 (0.596–2.197)
Systolic arterial blood pressure < 100mmHgb 110 10 (9.1) 95 21 (22.1) 205 31 (15.1) 0.012 2.838 (1.261–6.384)
Diastolic arterial blood pressure > 100mmHgb 110 2 (1.8) 95 2 (2.1) 205 4 (2.0) 0.882 1.161 (0.160–8.407)
Diastolic arterial blood pressure < 60mmHgb 110 73 (66.4) 95 73 (76.8) 205 146 (71.2) 0.100 1.682 (0.905–3.125)
Mean arterial blood pressure > 110mmHgb 99 8 (8.1) 83 9 (10.8) 182 17 (9.3) 0.525 1.383 (0.509–3.763)
Mean arterial blood pressure < 65mmHgb 99 9 (9.1) 83 17 (20.5) 182 26 (14.3) 0.033 2.576 (1.081–6.137)
PaO2 < 80mmHgb 93 66 (71.0) 83 64 (77.1) 176 130 (73.9) 0.356 1.378 (0.698–2.721)
SpO2 < 95%b 110 28 (25.5) 94 37 (39.4) 204 65 (31.9) 0.035 1.901 (1.047–3.450)
Administration of vasopressors 111 38 (34.2) 95 35 (36.8) 206 73 (35.4) 0.697 1.121 (0.632–1.986)
Duration of administration of vasopressors 111 95 206 0.648
0 days 72 (64.9) 60 (63.2) 132 (64.1)
1–3 days 23 (20.7) 17 (17.9) 40 (19.4) 0.742 0.887 (0.434–1.812)
4–6 days 16 (14.4) 18 (18.9) 34 (16.5) 0.436 1.350 (0.634–2.874)
Administration of Inotropics 111 3 (2.7) 95 10 (10.5) 206 13 (6.3) 0.032 4.235 (1.130–15.872)
Duration of administration of inotropics 111 95 206 0.434
0 days 108 (97.3) 85 (89.5) 193 (93.7)
1–3 days 3 (2.7) 6 (6.3) 9 (4.4) 0.196 2.541 (0.617–10.458)
4–6 days 0 (0.0) 4 (4.2) 4 (4.2) 0.999 N/A
Administration of antibiotics 111 91 (82.0) 95 81 (85.3) 206 172 (83.5) 0.528 1.272 (0.603–2.680)
Amount of antibiotics 111 95 206 0.804
0 20 (18.1) 14 (14.7) 34 (16.5)
1–2 73 (65.8) 64 (67.4) 137 (66.5) 0.562 1.252 (0.585–2.681)
3–5 18 (16.2) 17 (17.9) 35 (17.0) 0.537 1.349 (0.521–3.495)
Administration of Penicillin 111 49 (44.1) 95 45 (47.4) 206 94 (45.6) 0.643 1.139 (0.657–1.974)
Duration of administration of antibiotics 111 95 206 0.835
0 days 20 (18.0) 15 (15.8) 35 (17.0)
1–3 days 23 (20.7) 18 (18.9) 41 (19.9) 0.927 1.043 (0.420–2.593)
4–6 days 68 (61.3) 62 (65.3) 130 (63.1) 0.611 1.216 (0.573–2.581)
Skin condition
Administration of steroids 111 33 (29.7) 95 37 (38.9) 206 70 (34.0) 0.165 1.508 (0.845–2.691)
Duration of administration of steroids 111 95 206 0.131
0 days 79 (71.2) 57 (60.0) 136 (66.0)
1–3 days 10 (9.0) 17 (17.9) 27 (13.1) 0.049 2.356 (1.005–5.524)
4–6 days 22 (19.8) 21 (22.1) 43 (20.9) 0.425 1.323 (0.665–2.633)
Obesity 111 23 (20.7) 95 28 (29.5) 206 51 (24.8) 0.148 1.599 (0.846–3.022)
Underweight 111 6 (5.4) 95 9 (9.5%) 206 15 (7.3) 0.268 1.831 (0.627–5.348)
Presence of malnutrition
Serum albumin < 35 g/La 66 58 (87.9) 71 67 (94.4) 137 125 (91.2) 0.189 2.310 (0.661–8.069)
Serum albumin < 30 g/La 66 45 (68.2) 71 59 (83.1) 137 104 (75.9) 0.044 2.294 (1.022–5.149)
Serum albumin < 25 g/La 66 25 (37.9) 71 36 (50.7) 137 61 (44.5) 0.132 1.687 (0.854–3.333)
Serum albumin < 20 g/La 66 5 (7.6) 71 9 (12.7) 137 14 (10.2) 0.330 1.771 (0.561–5.587)
Presence of diabetes 111 19 (17.1) 95 35 (36.8) 206 54 (26.2) 0.002 2.825 (1.480–5.391)
Use of diapers 111 66 (59.5) 95 47 (49.5) 206 113 (54.9) 0.152 0.668 (0.384–1.160)
(continued on next page)
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Table 3 (continued)
IAD no IAD yes Total
Total n (%)/Mean (SD) Total n (%) Mean
(SD)
Total n (%) Mean
(SD)
P value OR
Skin cleansing at incontinence
Use of soap and water 111 16 (14.4) 95 16 (16.8) 206 32 (15.5) 0.632 1.203 (0.565–2.557)
Use of cleansing foam or milk 111 39 (35.1) 95 35 (36.8) 206 74 (35.9) 0.799 1.077 (0.609–1.906)
Use of antiseptics 111 25 (22.5) 95 28 (29.5) 206 53 (25.7) 0.256 1.438 (0.768–2.691)
Use of impregnated disposable washgloves 111 52 (46.8) 95 45 (47.4) 206 97 (47.1) 0.940 1.021 (0.590–1.768)
Application of skin barrier products
Application of barrier cream 111 35 (31.5) 95 58 (61.1) 206 93 (45.1) < 0.001 3.404 (1.916–6.048)
Application of barrier spray 111 21 (18.9) 95 18 (18.9) 206 39 (18.9) 0.996 1.002 (0.498–2.016)
Presence of urinary incontinence 111 3 (2.7) 95 4 (4.2) 206 7 (3.4) 0.555 1.582 (0.345–7.255)
Presence of loose or liquid stool
Presence of loose stool (Bristol type 6) 111 42 (37.8) 95 33 (34.7) 206 75 (36.4) 0.645 0.874 (0.494–1.547)
Duration of loose stool 111 95 206 0.814
0 days 69 (62.2) 62 (65.3) 131 (63.6)
1–3 days 20 (18.0) 14 (14.7) 34 (16.5) 0.522 0.779 (0.363–1.673)
4–6 days 22 (19.8) 19 (20.0) 41 (19.9) 0.912 0.961 (0.476–1.942)
Presence of liquid stool (Bristol type 7) 111 40 (36.0) 95 56 (58.9) 206 96 (46.6) 0.001 2.549 (1.451–4.476)
Duration of liquid stool 111 95 206 <0.001
0 days 71 (64.0) 39 (41.1) 110 (53.4)
1–3 days 28 (25.2) 24 (25.3) 52 (25.2) 0.194 1.560 (0.798–3.052)
4–6 days 12 (10.8) 32 (33.7) 44 (21.4) < 0.001 4.855 (2.248–10.484)
Presence of Clostridium diﬃcile 111 5.0 (4.5) 92 4 (4.3) 203 9 (4.4) 0.957 0.964 (0.251–3.698)
Presence of mechanical chaﬁng
(Potential) problem of friction and shear (Braden
subscale)
111 75 (67.6) 95 74 (77.9) 206 149 (72.3) 0.100 1.691 (0.904–3.165)
Bedbound 111 77 (69.4) 95 68 (71.6) 206 145 (70.4) 0.729 1.112 (0.609–2.029)
Low hemoglobin level
Hemoglobin level < 8 g/dLa 110 34 (30.9) 95 41 (43.2) 205 75 (36.6) 0.070 1.697 (0.957–3.010)
Hemoglobin level < 9 g/dLa 110 44 (40.0) 95 51 (53.7) 205 95 (46.3) 0.051 1.739 (0.998–3.029)
Hemoglobin level < 10 g/dLa 110 57 (51.8) 95 68 (71.6) 205 125 (61.0) 0.004 2.342 (1.309–4.191)
Nutritional support
Administration of enteral nutrition 111 86 (77.5) 95 68 (71.6) 206 154 (74.8) 0.332 0.732 (0.390–1.375)
Duration of enteral nutrition 108 91 199 0.280
0 days 26 (24.1) 27 (29.7) 53 (26.6)
1–10 days 37 (34.3) 36 (39.6) 73 (36.7) 0.857 0.937 (0.462–1.901)
> 10 days 45 (41.7) 28 (30.8) 73 (36.7) 0.161 0.599 (0.293–1.226)
Administration of parenteral nutrition 111 9 (8.1) 95 21 (22.1) 206 30 (14.6) 0.006 3.216 (1.394–7.422)
Duration of parenteral nutrition 111 95 206 0.018
0 days 102 (91.9) 74 (77.9) 176 (85.4)
1–7 days 5 (4.5) 16 (16.8) 21 (10.2) 0.006 4.411 (1.547–12.577)
> 7 days 4 (3.6) 5 (5.3) 9 (4.4) 0.429 1.723 (0.447–6.636)
Diminished cognitive awareness
GCS < 9 104 59 (56.7) 81 39 (48.1) 185 98 (53.0) 0.247 1.412 (0.788–2.531)
RASS≤−3 67 34 (50.7) 56 26 (46.4) 123 60 (48.8) 0.633 0.841 (0.413–1.712)
RASS≤−4 67 28 (41.8) 56 18 (32.1) 123 46 (37.4) 0.272 0.660 (0.314–1.385)
SD: standard deviation, OR: odds ratio, CI: conﬁdence interval, APACHE II: Acute Physiology and Chronic Health Evaluation; PaO2: partial oxygen pressure; SpO2: oxygen saturation
measured by pulse oxymetry; Bristol: Bristol Stool Chart, GCS: Glasgow Coma Scale; RASS: Richmond Agitation-Sedation Scale
a Lab values, except PaO2, were recoded in two categories: at least one measurement above or below the cut-oﬀ (no/yes).
b Clinical parameters and lab values (PaO2), measured several times a day, were also recoded into 2 categories: at least one day most of the time (≥50%) above or below the cut-oﬀ
(no/yes).
Table 4
Multivariate binary logistic regression for association between possible risk factor and IAD category 2.
Beta coeﬃcient Standard error Wald statistic OR (95% CI) P value
Liquid stool 1.545 0.367 17.726 4.686 (2.283–9.619) <0.001
Diabetes 1.062 0.394 7.257 2.893 (1.336–6.266) 0.007
Age 0.048 0.014 11.987 1.049 (1.021–1.078) 0.001
Smoking 0.982 0.406 5.863 2.670 (1.206–5.914) 0.015
Use of diapers −1.088 0.387 7.894 0.337 (0.158–0.720)a 0.005
Fever (> 38 °C) 0.957 0.384 6.199 2.603 (1.226–5.528) 0.013
Inotropics 1.413 0.807 3.069 4.109 (0.845–19.970) 0.080
Low oxygen saturation 0.767 0.374 4.203 2.154 (1.034–4.484) 0.040
Parenteral nutrition 1.043 0.532 3.844 2.839 (1.000–8.055) 0.050
Vasopressors 0.675 0.396 2 914 1.964 (0.905–4.265) 0.088
Constant −4.646 1.032 20.267 0.010 <0.001
IAD: incontinence-associated dermatitis, OR: odds ratio, CI: conﬁdence interval, Bristol: Bristol Stool Chart, SpO2: oxygen saturation measured by pulse oxymetry.
Nagelkerke R2= 0.377.
a The inverse OR (95% CI) of ‘Use of diapers’ is 2.967 (1.389–6.329).
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Damme et al., 2017). However, another ICU study (Bliss et al., 2011)
conﬁrmed our observation that most critically ill patients had a (po-
tential) problem of friction and shear, which may be the reason for not
identifying a diﬀerence between patients with and without IAD. As a
consequence, it is not plausible to conclude that friction and shear is not
risk factor for IAD in ICU patients.
Similar to the study of Van Damme et al. (2017), we were not able
to determine diﬀerences in the eﬀectiveness of various skin cleansing
regimens. A possible explanation for this ﬁnding may be the use of
diﬀerent cleansing products for continence care in the same patients. As
described in literature (Coyer et al., 2011; Musuuza et al., 2017),
cleansing practices varied from nurse to nurse, depending on nurse-
related factors (attitudes, believes, knowledge, perceptions), patient-
related factors (e.g. clinical stability), and organisational factors (e.g.
staﬃng). In addition, we observed that in most patients, leave-on pro-
ducts were only initiated once IAD category 2 has developed, and not as
a preventive measure as recommended (Beeckman et al., 2015). Our
ﬁndings may indicate that skin cleansing, without additional applica-
tion of leave-on products, is not suﬃcient to prevent IAD development
in high risk patients. According to Kottner and Surber (2016), skin
cleansing practices may even contribute in some degree to a decrease in
skin barrier properties. Therefore, the use of a deﬁned skin care pro-
tocol, including skin cleansing, as well as the application of leave-on
products, is recommended to reduce the prevalence of IAD (Beeckman
et al., 2015, 2016). Skin cleansing should be performed at least, and as
soon as possible, after each fecal incontinence episode (Beeckman et al.,
2015; Kottner and Beeckman, 2015). A pH-balanced skin cleanser, or an
impregnated wipe with cleansing, moisturising and skin protecting
properties performs better in the prevention of IAD than soap and water
(Beeckman et al., 2016). Leave-on products should be used according to
the guidelines of the manufacturer. As these products often contain a
mix of moisturising ingredients (humectants, emollients), and protec-
tive ingredients (ﬁlm forming, hydrophobic), the actual performance
depends on the overall formulation and the frequency of application
(Kottner and Beeckman, 2015; Woo et al., 2017). A range of products
and procedures for IAD prevention already exists (Beeckman et al.,
2016). However, the evidence concerning the eﬀectiveness of skin care
products and procedures is weak (Beeckman et al., 2016; Kottner and
Surber, 2016). As it is still unclear which interventions are eﬀective for
the prevention and treatment of IAD in critically ill patients, rigorously
performed research on this topic is needed.
4.1. Strengths and limitations
Our study was performed in 27 hospitals across Belgium. The results
reﬂect risk factors identiﬁed in a range of ICU wards (n=48), char-
acterised by varying organisational, staﬀ, and patient characteristics, as
well as skin care practices. This promotes generalisability of our ﬁnd-
ings. Furthermore, data collection was performed on site by re-
searchers, experienced in assessment and classiﬁcation of IAD and
pressure ulcers, who purposefully searched all patients records.
Performing the data collection on the ward, promoted the completeness
of the data, as nurses and patients could be consulted in real time (e.g.
on skin care practices, stool consistency, smoking behavior). In addi-
tion, researchers could take the current patient situation into account
while diﬀerentiating IAD from other skin problems (e.g. pressure ulcers,
friction). On site data collection by trained researchers, under super-
vision of a skin care expert, optimised the validity and reliability of our
results.
Our study was conducted using a cross-sectional observational de-
sign, including the performance of direct skin assessments at one point
in time. This prevented us to study associations between potential IAD
risk factors and the time to IAD development (Bliss et al., 2011). It is
also possible that in some patients IAD developed following completion
of the data collection. However, in the study of Bliss et al. (2011), the
median time to IAD development was 4 days (range 1–6 days) and the
median length of stay in our study was 14 days. Due to the cross-sec-
tional character of our study, some data could not be completed in
every patient due to lack of registration in the patient record. This,
however, happened occasionally.
Data were collected on patient health-related risk factors to be able
to identify high risk patients in need for speciﬁc interventions.
However, the development of IAD may also depend upon nurse-related
factors (e.g. knowledge and attitude) and organisational factors (e.g.
staﬃng levels) (Bliss et al., 2017).
5. Conclusions
Liquid stool, diabetes, age, smoking, non-use of diapers, fever, and
low oxygen saturation were independently associated with IAD cate-
gory 2 in critically ill patients with fecal incontinence. These risk factors
are theoretically plausible and provide important guidance to identify
high risk ICU patients in need for speciﬁc IAD prevention strategies.
The use of a skin care protocol, including gentle skin cleansing, and the
application of leave-on products to maintain or restore skin barrier
function is recommended. Eﬀorts should now be targeted at the de-
velopment of preventive interventions being eﬀective in high risk pa-
tients.
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